TimeScale Financial’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

TimeScale Financial’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$3.25K	Sell	39 -24	-38%	-$2.01K	﹤0.01%	476
2023 Q1	$4.81K	Buy	63 +24	+62%	+$1.99K	﹤0.01%	422
2022 Q4	$3.1K	Hold	39	–	–	﹤0.01%	430
2022 Q3	$3K	Hold	39	–	–	﹤0.01%	440
2022 Q2	$3K	Hold	39	–	–	﹤0.01%	417
2022 Q1	$4K	Hold	39	–	–	﹤0.01%	407
2021 Q4	$4K	Hold	39	–	–	﹤0.01%	405
2021 Q3	$5K	Hold	39	–	–	﹤0.01%	382
2021 Q2	$5K	Hold	39	–	–	﹤0.01%	390
2021 Q1	$5K	Hold	39	–	–	﹤0.01%	388
2020 Q4	$5K	Sell	39 -28	-42%	-$3.59K	﹤0.01%	343
2020 Q3	$8K	Buy	+67	New	+$7.51K	﹤0.01%	320
2020 Q1	–	Sell	-179	Closed	-$17K	–	549
2019 Q4	$17K	Sell	179 -48	-21%	-$4.15K	0.01%	301
2019 Q3	$17K	Hold	227	–	–	0.01%	305
2019 Q2	$20K	Buy	+227	New	+$19.4K	0.01%	287

Other funds holding XBI

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

APF

Alaska Permanent Fund Juneau, Alaska $1.51B AUM 22.23% 1-Year Est. Return

TimeScale Financial's XBI Position: Q2 2023 in Review

TimeScale Financial reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 38% in Q2 2023, selling an estimated $2.01K and leaving 39 shares worth $3.25K. The position accounts for ﹤0.01% of the portfolio, ranked #476.

TimeScale Financial first reported a position in XBI in Q2 2019 and has held it in 15 quarters since. The position peaked at $20K in Q2 2019. 712 funds tracked by Wall St. Rank hold XBI as of Q2 2023.

TimeScale Financial held 39 shares of State Street SPDR S&P Biotech ETF worth $3.25K as of Q2 2023.
TimeScale Financial sold 24 State Street SPDR S&P Biotech ETF shares in Q2 2023, an estimated $2.01K.
State Street SPDR S&P Biotech ETF made up ﹤0.01% of TimeScale Financial's portfolio in Q2 2023, its #476 holding.
TimeScale Financial first reported a position in State Street SPDR S&P Biotech ETF in Q2 2019 and has held it in 15 quarters since.
TimeScale Financial's State Street SPDR S&P Biotech ETF position peaked at $20K in Q2 2019.
712 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2023.

Based on TimeScale Financial's 13F filing for Q2 2023, filed 27 Jul 2023.